NM_001845.6:c.1897+29A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.1897+29A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 1,611,298 control chromosomes in the GnomAD database, including 107,680 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 9921 hom., cov: 33)
Exomes 𝑓: 0.36 ( 97759 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.712

Publications

10 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-110186356-T-C is Benign according to our data. Variant chr13-110186356-T-C is described in ClinVar as Benign. ClinVar VariationId is 1261039.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.1897+29A>G
intron
N/ANP_001836.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.1897+29A>G
intron
N/AENSP00000364979.4
COL4A1
ENST00000650424.2
c.1897+29A>G
intron
N/AENSP00000497477.2
COL4A1
ENST00000615732.3
TSL:5
c.1705+29A>G
intron
N/AENSP00000478222.3

Frequencies

GnomAD3 genomes
AF:
0.361
AC:
54848
AN:
152012
Hom.:
9904
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.343
Gnomad AMI
AF:
0.607
Gnomad AMR
AF:
0.369
Gnomad ASJ
AF:
0.330
Gnomad EAS
AF:
0.468
Gnomad SAS
AF:
0.340
Gnomad FIN
AF:
0.342
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.365
Gnomad OTH
AF:
0.370
GnomAD2 exomes
AF:
0.366
AC:
90701
AN:
247764
AF XY:
0.363
show subpopulations
Gnomad AFR exome
AF:
0.347
Gnomad AMR exome
AF:
0.400
Gnomad ASJ exome
AF:
0.304
Gnomad EAS exome
AF:
0.468
Gnomad FIN exome
AF:
0.345
Gnomad NFE exome
AF:
0.360
Gnomad OTH exome
AF:
0.353
GnomAD4 exome
AF:
0.364
AC:
531200
AN:
1459168
Hom.:
97759
Cov.:
37
AF XY:
0.363
AC XY:
263589
AN XY:
725918
show subpopulations
African (AFR)
AF:
0.338
AC:
11294
AN:
33442
American (AMR)
AF:
0.397
AC:
17769
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.307
AC:
8032
AN:
26128
East Asian (EAS)
AF:
0.468
AC:
18584
AN:
39696
South Asian (SAS)
AF:
0.337
AC:
28953
AN:
85940
European-Finnish (FIN)
AF:
0.345
AC:
18101
AN:
52402
Middle Eastern (MID)
AF:
0.265
AC:
1301
AN:
4912
European-Non Finnish (NFE)
AF:
0.365
AC:
405369
AN:
1111664
Other (OTH)
AF:
0.362
AC:
21797
AN:
60270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
17962
35924
53886
71848
89810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12926
25852
38778
51704
64630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.361
AC:
54908
AN:
152130
Hom.:
9921
Cov.:
33
AF XY:
0.360
AC XY:
26788
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.343
AC:
14225
AN:
41520
American (AMR)
AF:
0.369
AC:
5649
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
1143
AN:
3466
East Asian (EAS)
AF:
0.468
AC:
2412
AN:
5152
South Asian (SAS)
AF:
0.342
AC:
1649
AN:
4822
European-Finnish (FIN)
AF:
0.342
AC:
3619
AN:
10584
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.365
AC:
24779
AN:
67968
Other (OTH)
AF:
0.375
AC:
792
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1871
3742
5613
7484
9355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
2018
Bravo
AF:
0.364
Asia WGS
AF:
0.418
AC:
1451
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.048
DANN
Benign
0.29
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2305080; hg19: chr13-110838703; COSMIC: COSV65429663; COSMIC: COSV65429663; API